Clinical trial
Primary Progesterone Therapy for Operable Breast Cancer
NCT00123669 · Tata Memorial Hospital, Other · Completed
Key facts
| NCT number | NCT00123669 |
|---|---|
| Title | Primary Progesterone Therapy for Operable Breast Cancer |
| Official title | The Primary Progesterone Therapy for Operable Breast Cancer : A Randomized Controlled Trial |
| Lead sponsor | Tata Memorial Hospital, Other |
| Collaborators | Ministry of Science and Technology, India |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | 500 mg of depot hydroxy-progesterone |
| Enrollment | 1,000 |
| Start date | Oct 1, 1997 |
| Primary completion | May 29, 2020 |
| Completion | May 29, 2020 |
| First posted | Jul 25, 2005 |
| Last update posted | Jul 22, 2020 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: